LifeStance Health Group, Inc. — Form 8-K Summary
Business Context and Reporting Period
LifeStance Health Group, Inc. filed a Form 8-K dated November 8, 2021 under Items 2.02, 7.01, and 9.01. The filing announces the company’s results of operations for the third quarter ended September 30, 2021 and furnishes supplemental investor information.
Financial Results and Key Metrics
The filing text identifies a press release and slide presentation but does not include their underlying financial data. Revenue, profit or loss, cash flow, margins, debt, liquidity, operating metrics, and other key financial values are not clearly provided in the supplied text.
Material Changes Versus Prior Period
The filing text does not provide a clear comparison with the prior comparable period or quantify any material changes.
Guidance, Outlook, Risks, and Unusual Items
- No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the supplied filing text.
- Exhibit 99.1 contains the November 8, 2021 earnings press release, and Exhibit 99.2 contains a supplemental slide presentation; their contents are not included in the provided text.
- The information furnished under Items 2.02 and 7.01, including the exhibits, is not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other SEC filings unless expressly stated.
Investor Verification Items
- Review Exhibit 99.1 for third-quarter revenue, profitability, cash flow, operating metrics, and management guidance.
- Review Exhibit 99.2 for supplemental operating, financial, and strategic information.
- Verify any reported year-over-year or sequential changes against the company’s prior filings.
- Confirm debt, liquidity, cash balance, non-GAAP measures, and related reconciliations in the underlying earnings materials.